Načítá se...
Agonist actions of dihydroergotamine at 5-HT(2B) and 5-HT(2C) receptors and their possible relevance to antimigraine efficacy
1. The pharmaceutical compound, dihydroergotamine (DHE) is dispensed to prevent and reduce the occurrence of migraine attacks. Although still controversial, the prophylactic effect of this drug is believed to be caused through blockade and/or activation of numerous receptors including serotonin (5-H...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2003
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1574033/ https://ncbi.nlm.nih.gov/pubmed/12970106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705437 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|